金融困境及其在类风湿关节炎的决定因素
Amber Brown Keebler1, Yunju Im2, Sofia Pedro3
1Division of General Internal Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha.
Arthritis care & research
|October 16, 2025
概括
风湿性关节炎 (RA) 患者,特别是那些患有抑郁症的人,经常遇到财务困难. 昂贵的RA药物与财务毒性无关.
科学领域:
- 类风湿病学 类风湿病学
- 卫生经济学 卫生经济学
- 患者报告的结果
背景情况:
- 类风湿性关节炎 (RA) 管理涉及长期使用昂贵的疾病修饰疗法.
- 了解RA患者的财务负担对于综合护理至关重要.
研究的目的:
- 量化RA成年人的财务困难.
- 确定导致RA患者经济困境的因素.
主要方法:
- 来自FORWARD数据库的RA和非炎症性肌肉骨疾病 (NIMSKD) 患者的横截面分析.
- 使用了慢性疾病治疗功能评估-财务毒性综合评分 (FACIT-COST) 问卷.
- 应用最小绝对收缩和选择运算符 (LASSO) 回归用于共变量选择.
主要成果:
- 与NIMSKD患者相比,RA患者报告的财务困难明显更大 (FACIT-COST得分更低).
- 与NIMSKD患者 (15%) 相比,RA患者 (29%) 的财务困难更为普遍.
- 抑郁症和疾病严重程度被确定为RA经济困境的关键决定因素.
结论:
- 对于RA成年人来说,财务困难是一个重要的问题,特别是那些患有抑郁症等并发症的人.
- 伴随性疾病,特别是抑郁症,是缓解金融毒性的干预措施的潜在目标.
- 生物或向合成疾病修饰性抗风湿药物的成本与财务困境无关.
相关概念视频
Rheumatic Heart Disease I: Introduction
426
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
476
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476
Rheumatic Heart Disease IV: Nursing Management
264
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
264
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Rheumatic Heart Disease III: Medical Management
282
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
282
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K


